Safety and Performance Assessment of Drug-Eluting Stent CRE8 in Diabetic Patients

Safety and Performance Assessment of Coronary Drug-Eluting Stent CRE8 : Post-market Observationnal Study

The study is a 'real-world' study which evaluates the safety and performance of the coronary DES-CRE8 in diabetic patients.

As routine care, each patient will be followed until 12 months after stent implantation.

Inclusion Criteria:

• ≥18 years old,
• patient informed and agreed to participate,
• patient with one or more lesions treated with one or more coronary stent CRE8,
• patient with a diabete insulin dependent or non-insulin dependant.

Exclusion Criteria:

• pregnant or breast-feading women,
• patient who refused to participate,
• patient with another lesion treated during the same intervention with a balloon alone or with another stent